The content on this site is intended for healthcare professionals only
Molecular mechanisms of breast cancer tumours
Published: 12 Jan 2009
Views: 16264
Dr. Kornelia Polyak, Dana-Farber Cancer Institute
Investigating breast cancer tumour evolution and therapeutic resistance
- Categories:
- Breast
- Cell therapy & stem cells
Related Videos
OncoAlert and ecancer - ESMO 2021 Day 5
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
21 Sep 2021
OncoAlert and ecancer - ESMO 2021 Day 4
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
20 Sep 2021
6 months trastuzumab non-inferior to 12 months for HER2 positive early breast ca...
Prof Helena Earl - University of Cambridge, Cambridge, United Kingdom
17 Sep 2021
OncoAlert and ecancer weekly round up for August 23rd - August 29th, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
31 Aug 2021
OncoAlert and ecancer weekly round up for July 26 - August 1, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
2 Aug 2021
OncoAlert and ecancer weekly round up for July 12- July 18, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
19 Jul 2021
Escalation and descalation in neoadjuvant time to treatment of TNBC
Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
3 Feb 2021
BRCA mutation in metastatic TNBC patients
Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon
28 Jan 2021
Synchronous invasive ductal carcinoma of the breast and clear cell renal carcino...
Dr Mona Hassan - American University of Beirut Medical Center, Beirut, Lebanon
8 Oct 2020
